サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1417390

持続的腎代替療法の世界市場：動向、予測、競合分析（～2030年）

Continuous Renal Replacement Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 - page report | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

持続的腎代替療法の世界市場：動向、予測、競合分析（～2030年）
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の持続的腎代替療法の市場規模は、2024～2030年にかけてCAGR 8.3%で成長し、2030年までに約26億米ドルに達すると予測されています。この市場の主な促進要因は、急性腎障害（AKI）の急増、AKIを経験するICU患者数の増加、敗血症の発生率の上昇、間欠的な血液浄化と比較した持続的腎代替療法（CRRT）の臨床的メリットの高まりです。世界の持続的腎代替療法市場の将来は、透析液・補液、ディスポーザブル、血液フィルター、血液ラインセット・チューブ市場に機会があり、有望視されています。

持続的腎代替療法市場の洞察

Lucintelの予測では、成人の間でクリアアライナーや見えない歯列矯正に対する要望が高まっているため、予測期間中も成人向けがより大きなセグメントであり続けると思われます。

この市場では、不要な溶質を除去し、血液中の電解質と酸塩基平衡を回復するための透析液の必要性が高まっているため、透析液と透析用補液が引き続き最大の市場分野となるでしょう。

北米は、急性腎障害（AKI）の発生と頻度の増加、および同地域における高齢者人口の急増により、予測期間中も最大の地域であり続けるでしょう。

よくある質問

Q1.市場規模は？

A1.世界の持続的腎代替療法市場は、2030年までに推定26億米ドルに達すると予想されています。

Q2.市場の成長予測は？

A2.世界の持続的腎代替療法市場は、2024～2030年にかけてCAGR 8.3%で成長する見込みです。

Q3.市場の成長に影響を与える主な促進要因は？

A3.この市場の主な促進要因は、急性腎障害（AKI）の急増、AKIを経験するICU患者数の増加、敗血症の発生率の上昇、間欠的な血液浄化と比較した持続的腎代替療法（CRRT）の臨床的メリットの高まりです。

Q4.市場の主要セグメントは？

A4.世界の持続的腎代替療法市場の将来は、透析液・補液、ディスポーザブル、血液フィルター、血液ラインセット・チューブ市場に機会があり、有望です。

Q5.市場の主要企業は？

A5.持続的腎代替療法の主要企業は以下の通りです。

  • Baxter International
  • Fresenius Medical Care
  • B. Braun Melsungen
  • NIKKISO
  • Medtronic

Q6.今後、最大となる市場セグメントは？

A6.Lucintelは、成人の間でクリアアライナーや見えない歯列矯正への欲求が高まっているため、予測期間中、成人のセグメントが引き続き大きくなると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は？

A7.北米は、急性腎障害（AKI）の発生と頻度の増加、および同地域の老人人口の急増により、予測期間中も最大の地域です。

Q8.レポートのカスタマイズは可能？

A8.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の持続的腎代替療法市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 市場動向と予測分析（2018～2030年）

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の持続的腎代替療法市場の動向（2018～2023年）と予測（2024～2030年）
  • 世界の持続的腎代替療法市場：製品別
    • 透析液・補液
    • ディスポーザブル
    • 血液フィルター
    • 血液ラインセット・チューブ
    • その他
  • 世界の持続的腎代替療法市場：モダリティ別
    • 持続的静脈静脈血液濾過（CVVH）
    • 持続的静脈血液透析濾過（CVVHDF）
    • 持続的静脈静脈血液透析（CVVHD）
    • 低速連続限外濾過（SCUF）
  • 世界の持続的腎代替療法市場：年齢層別
    • 大人
    • 小児科・新生児
  • 世界の持続的腎代替療法市場：最終用途別
    • 病院
    • 外来診療
    • ホームケア
    • その他

第4章 市場動向と予測分析：地域別（2018～2030年）

  • 世界の持続的腎代替療法市場：地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品別
    • モダリティ別
    • 年齢層別
    • 最終用途別
    • 地域別
  • 世界の持続的腎代替療法市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の持続的腎代替療法市場の能力拡大
    • 世界の持続的腎代替療法市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Baxter International
  • Fresenius Medical Care
  • B. Braun Melsungen
  • NIKKISO
  • Medtronic
目次

Continuous Renal Replacement Trends and Forecast

The future of the global continuous renal replacement market looks promising with opportunities in the dialysates and replacement fluid, disposable, hemofilter, and bloodline sets & tube markets. The global continuous renal replacement market is expected to reach an estimated $2.6 billion by 2030 with a CAGR of 8.3% from 2024 to 2030. The major drivers for this market are surging occurrence of acute kidney injury (AKI), escalating count of icu patients experiencing AKI, rising occurrence of sepsis, and mounting clinical benefits of continuous renal replacement therapy (CRRT) compared to intermittent blood purification.

A more than 150-page report is developed to help in your business decisions.

Continuous Renal Replacement by Segment

The study includes a forecast for the global continuous renal replacement by product, modality, age group, end use, and region.

Continuous Renal Replacement Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Dialysates and Replacement Fluids
  • Disposables
  • Hemofilters
  • Bloodline Sets & Tubes
  • Other

Continuous Renal Replacement Market by Modality [Shipment Analysis by Value from 2018 to 2030]:

  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)
  • Continuous Venovenous Haemodialysis (CVVHD)
  • Slow Continuous Ultrafiltration (SCUF)

Continuous Renal Replacement Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

  • Adults
  • Pediatrics /Neonates

Continuous Renal Replacement Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital
  • Ambulatory Care
  • Homecare
  • Others

Continuous Renal Replacement Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Continuous Renal Replacement Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies continuous renal replacement companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the continuous renal replacement companies profiled in this report include-

  • Baxter International
  • Fresenius Medical Care
  • B. Braun Melsungen
  • NIKKISO
  • Medtronic

Continuous Renal Replacement Market Insights

Lucintel forecasts that adult will remain the larger segment over the forecast period due to growing desire for clear aligners or invisible braces among adults.

Within this market, dialysates & replacement fluid will remain the largest segment due to increasing need for dialysate solutions so as to remove unwanted solutes as well as restores the electrolytes and acid-base balance in the blood.

North America will remain the largest region over the forecast period due to rising occurrence and frequency of acute kidney injury (AKI) and surge in geriatric population in the region.

Features of the Global Continuous Renal Replacement Market

Market Size Estimates: Continuous renal replacement market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Continuous renal replacement market size by various segments, such as by product, modality, age group, end use, and region in terms of value ($B).

Regional Analysis: Continuous renal replacement market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, modalities, age groups, end uses, and regions for the continuous renal replacement market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the continuous renal replacement market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the continuous renal replacement market size?

Answer: The global continuous renal replacement market is expected to reach an estimated $2.6 billion by 2030.

Q2. What is the growth forecast for continuous renal replacement market?

Answer: The global continuous renal replacement market is expected to grow with a CAGR of 8.3% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the continuous renal replacement market?

Answer: The major drivers for this market are surging occurrence of acute kidney injury (AKI), escalating count of icu patients experiencing AKI, rising occurrence of sepsis, and mounting clinical benefits of continuous renal replacement therapy (CRRT) compared to intermittent blood purification.

Q4. What are the major segments for continuous renal replacement market?

Answer: The future of the global continuous renal replacement market looks promising with opportunities in the dialysates and replacement fluid, disposable, hemofilter, and bloodline sets & tube markets.

Q5. Who are the key continuous renal replacement market companies?

Answer: Some of the key continuous renal replacement companies are as follows.

  • Baxter International
  • Fresenius Medical Care
  • B. Braun Melsungen
  • NIKKISO
  • Medtronic

Q6. Which continuous renal replacement market segment will be the largest in future?

Answer: Lucintel forecasts that adult will remain the larger segment over the forecast period due to growing desire for clear aligners or invisible braces among adults.

Q7. In continuous renal replacement market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising occurrence and frequency of acute kidney injury (AKI) and surge in geriatric population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the continuous renal replacement market by product (dialysates and replacement fluids, disposables, hemofilters, bloodline sets & tubes, and other), modality (continuous venovenous hemofiltration (CVVH), continuous venovenous hemodiafiltration (CVVHDF), continuous venovenous haemodialysis (CVVHD), and slow continuous ultrafiltration (SCUF)), age group (adults and pediatrics /neonates), end use (hospital, ambulatory care, homecare, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Continuous Renal Replacement Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Continuous Renal Replacement Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Continuous Renal Replacement Market by Product
    • 3.3.1: Dialysates and Replacement Fluids
    • 3.3.2: Disposables
    • 3.3.3: Hemofilters
    • 3.3.4: Bloodline Sets & Tubes
    • 3.3.5: Other
  • 3.4: Global Continuous Renal Replacement Market by Modality
    • 3.4.1: Continuous venovenous hemofiltration (CVVH)
    • 3.4.2: Continuous venovenous hemodiafiltration (CVVHDF)
    • 3.4.3: Continuous venovenous haemodialysis (CVVHD)
    • 3.4.4: Slow continuous ultrafiltration (SCUF)
  • 3.5: Global Continuous Renal Replacement Market by Age Group
    • 3.5.1: Adults
    • 3.5.2: Pediatrics /Neonates
  • 3.6: Global Continuous Renal Replacement Market by End Use
    • 3.6.1: Hospital
    • 3.6.2: Ambulatory care
    • 3.6.3: Homecare
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Continuous Renal Replacement Market by Region
  • 4.2: North American Continuous Renal Replacement Market
    • 4.2.2: North American Continuous Renal Replacement Market by Age Group: Adults and Pediatrics /Neonates
  • 4.3: European Continuous Renal Replacement Market
    • 4.3.1: European Continuous Renal Replacement Market by Product: Dialysates and Replacement Fluids, Disposables, Hemofilters, Bloodline Sets & Tubes, and Other
    • 4.3.2: European Continuous Renal Replacement Market by Age Group: Adults and Pediatrics /Neonates
  • 4.4: APAC Continuous Renal Replacement Market
    • 4.4.1: APAC Continuous Renal Replacement Market by Product: Dialysates and Replacement Fluids, Disposables, Hemofilters, Bloodline Sets & Tubes, and Other
    • 4.4.2: APAC Continuous Renal Replacement Market by Age Group: Adults and Pediatrics /Neonates
  • 4.5: ROW Continuous Renal Replacement Market
    • 4.5.1: ROW Continuous Renal Replacement Market by Product: Dialysates and Replacement Fluids, Disposables, Hemofilters, Bloodline Sets & Tubes, and Other
    • 4.5.2: ROW Continuous Renal Replacement Market by Age Group: Adults and Pediatrics /Neonates

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Continuous Renal Replacement Market by Product
    • 6.1.2: Growth Opportunities for the Global Continuous Renal Replacement Market by Modality
    • 6.1.3: Growth Opportunities for the Global Continuous Renal Replacement Market by Age Group
    • 6.1.4: Growth Opportunities for the Global Continuous Renal Replacement Market by End Use
    • 6.1.5: Growth Opportunities for the Global Continuous Renal Replacement Market by Region
  • 6.2: Emerging Trends in the Global Continuous Renal Replacement Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Continuous Renal Replacement Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Continuous Renal Replacement Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Baxter International
  • 7.2: Fresenius Medical Care
  • 7.3: B. Braun Melsungen
  • 7.4: NIKKISO
  • 7.5: Medtronic